Abivax Socit Anonyme Stock Today
| AAVXF Stock | USD 11.05 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 56
|
ABIVAX Société is trading at 11.05 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 11.05. ABIVAX Société has over 56 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for ABIVAX Socit Anonyme are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States. The company has 22.3 M outstanding shares. More on ABIVAX Socit Anonyme
Moving against ABIVAX Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ABIVAX Pink Sheet Highlights
| President | Alexandra Pearce |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ABIVAX Socit Anonyme [AAVXF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 165.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABIVAX Société's market, we take the total number of its shares issued and multiply it by ABIVAX Société's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ABIVAX Socit Anonyme classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 22.3 M outstanding shares.
ABIVAX Socit Anonyme has accumulated about 26.57 M in cash with (45.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Check ABIVAX Société Probability Of Bankruptcy
Ownership AllocationABIVAX Société holds a total of 22.3 Million outstanding shares. Over half of ABIVAX Société's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check ABIVAX Ownership Details
ABIVAX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ABIVAX Société without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
ABIVAX Société Corporate Management
| Alain Chevallier | Advisor | Profile | |
| Philippe MD | Founder Director | Profile | |
| Regina Jehle | VP Communications | Profile | |
| Prof Ehrlich | Chief Officer | Profile | |
| Paul Gineste | VP Operations | Profile | |
| Anne Pascard | HR Mang | Profile |
Other Information on Investing in ABIVAX Pink Sheet
ABIVAX Société financial ratios help investors to determine whether ABIVAX Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABIVAX with respect to the benefits of owning ABIVAX Société security.